Prevalence of lipid abnormalities in Poland. the NATPOL 2011 survey

Kardiologia Polska

Volumn 74, Issue 3, 2016, Pages 213-223

  Zdrojewski, Tomasz ^a,b   Solnica, Bogdan ^c   Cybulska, Barbara ^d   Bandosz, Piotr ^a   Rutkowski, Marcin ^a,e   Stokwiszewski, Jakub ^b   Gaciong, Zbigniew ^f   Banach, MacIej ^g,h   Wojtyniak, Bogdan ^b   Pencina, Michael ⁱ   Wyrzykowski, Bogdan ^a,e  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

^b NATIONAL INSTITUTE OF HYGIENE   (Poland)

^c JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^d NATIONAL FOOD AND NUTRITION INSTITUTE   (Poland)

^e UNIVERSITY OF GDA SK   (Poland)

^f MEDICAL UNIVERSITY OF WARSAW   (Poland)

^g MEDICAL UNIVERSITY OF LODZ   (Poland)

^h POLISH MOTHER S MEMORIAL HOSPITAL RESEARCH INSTITUTE   (Poland)

ⁱ DUKE CLINICAL RESEARCH INSTITUTE   (United States)

Author keywords

And control of dyslipidaemia; Awareness; Cross sectional; Lipids; Nationally representative survey; Prevalence

Indexed keywords

ANTILIPEMIC AGENT; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; AWARENESS; CHOLESTEROL BLOOD LEVEL; DISORDERS OF LIPID METABOLISM; DRUG EFFECT; FEMALE; HEALTH SURVEY; HUMAN; HYPERCHOLESTEROLEMIA; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; POLAND; PREVALENCE; SEX DIFFERENCE; TREND STUDY; TRIACYLGLYCEROL BLOOD LEVEL; YOUNG ADULT; ADOLESCENT; ATTITUDE TO HEALTH; BLOOD; CROSS-SECTIONAL STUDY; DYSLIPIDEMIAS; PSYCHOLOGY; QUESTIONNAIRE;

ADOLESCENT; ADULT; AGED; CHOLESTEROL; CROSS-SECTIONAL STUDIES; DYSLIPIDEMIAS; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; MIDDLE AGED; POLAND; PREVALENCE; SURVEYS AND QUESTIONNAIRES; TRIGLYCERIDES; YOUNG ADULT;

EID: 84989187401     PISSN: 00229032     EISSN: 18974279     Source Type: Journal    
DOI: 10.5603/KP.2016.0029     Document Type: Article

References (20)

1. Neaton JD, Blackburn H, Jacobs D et al. Serum cholesterol level mortality finding for men screened in Multiple Risk Factor Intervention Trial. Multiple Risk Factor Intervention Trial Research Group. Arch Intern Med, 1992; 152: 1490-1500.
2. Rynkiewicz A, Cybulska B, Banach M et al. Postepowanie w heterozygotycznej hipercholesterolemii rodzinnej. Stanowisko Forum Ekspertów Lipidowych. Kardiol Pol, 2013; 71, 1: 107-111.
3. Baigent C, Blackwell L, Emerson J et al. Efficacy and safety of more intensive lowering of LDL cholesterol: A meta-analysis of data from 170 000 participants in 26 randomised trials. Lancet, 2010; 376: 1670-1681. doi: 10. 1016/S0140-6736(10)61350-5.
4. Reiner Ž, Catapano AL, De Backer G et al. ESC/EAS guidelines for management of dyslipidaemias. The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Eur Heart J, 2011; 32: 1769-1818. doi: 10. 1093/eurheartj/ehr158.
5. Hegele RA, Ginsberg HN, Chapman MJ et al. The polygenic nature of hypertriglyceridaemia implications for definition, diagnosis, and management. Lancet Diabetes Endocrinol, 2014; 2: 655-666. doi: 10. 1016/S2213-8587(13)70191-8.
6. Cybulska B, Klosiewicz-Latoszek L. The HDL paradox: what does it mean and how to manage low serum HDL cholesterol level. Kardiol Pol, 2014; 72: 681-686. doi: 10. 5603/KP. A2014. 0110.
7. Otocka-Kmiecik A, Mikhailidis DP, Nicholls SJ et al. Dysfunctional HDL: A novel important diagnostic and therapeutic target in cardiovascular disease Prog Lipid Res, 2012; 51: 314-324. doi: 10. 1016/j. plipres. 2012. 03. 003.
8. Zdrojewski T, Bandosz P, Szpakowski P et al. Rozpowszechnienie glównych czynników ryzyka chorób ukladu sercowo-naczyniowego w Polsce. Wyniki badania NATPOL PLUS. Kardiol Pol, 2004; 61 (supl. 4): 546-558.
9. Pajak A, Wiercinska E, Polakowska M et al. Rozpowszechnienie dyslipidemii u mezczyzn i kobiet w wieku 20-74 lat w Polsce: wyniki programu WOBASZ. Prevalence of dyslipidemia in men and women between the ages of 20-74 in Poland. Results of the WOBASZ program. Kardiol Pol, 2005; 63 (suppl. 4): S620-S625.
10. Bledowski P, Mossakowska M, Chudek J et al. Medical, psychological and socioeconomic aspects of aging in Poland. Assumptions and objectives of the PolSenior project. Exp Gerontol, 2011; 46: 1003-1009. doi: 10. 1016/j. exger. 2011. 09. 006.
11. Zdrojewski T, Rutkowski M, Bandosz P et al. Prevalence and control of cardiovascular risk factors in Poland. Assumptions and objectives of the NATPOL 2011 Survey. Kardiol Pol, 2013; 71: 381-392. doi: 10. 5603/KP. 2013. 0066.
12. Mancia G, Fagard R, Narkiewicz K et al. 2013 ESH/ESC Guidelines for management of arterial hypertension of the European Society of Hypertension (CES) Hand of European Society of Cardiology (ESC). Eur. Heart J, 2013; 34: 2159-2219. doi: 10. 1093/eurheartj/eht151.
13. Bandosz P, O'Flaherty M, Rutkowski M et al. A victory for statins or a defeat for diet policies Cholesterol falls in Poland in the past decade: A modeling study. Int J Cardiol, 2015; 185: 313-319. doi: 10. 1016/j. ijcard. 2015. 03. 079.
14. Jarosz M, Sekula W. Poprawa zywienia i zwiekszenie aktywnosci fizycznej jako determinanty poprawy zdrowia. In: Szymborski J ed. Zdrowie publiczne i polityka ludnosciowa. Materialy z konferencji Rady Ludnosciowej. Warszawa 2012. ISBN 978-83-7027-489-4.
15. Ford ES, Mokdad AH, Giles WH, Mensah GA. Serum Total Cholesterol Concentrations and Awareness, Treatment, and Control of Hypercholesterolemia Among US Adults: Findings From the National Health and Nutrition Examination Survey, 1999 to 2000. Circulation, 2003; 107: 2185-2189.
16. Knopf H, Schienkiewitz A, Ziese T et al. Prevalence of dyslipidemia among adults in Germany. Results of the German Health Interview and Examination Survey for Adults (DEGS1). Bundesgesundheitsbl 2013; 56: 661-667. doi: 10. 1007/s00103-S013-1670-0.
17. Asghari S, Aref-Eshghi E, Hurley O et al. Does the prevalence of dyslipidemias differ between Newfoundland and the rest of Canada Findings from the electronic medical records of the Canadian Primary Care Sentinel Surveillance Network. Front Cardiovasc Med, 2015; 2: 1. doi: 10. 3389/fcvm. 2015. 00001.
18. Al-Kaabba AF, Al-Hamdan NA, El Tahir A et al. Prevalence and correlates of dyslipidemia among adults in saudi arabia: results from a national survey. Open J Endocr Metab Dis, 2012; 2: 89-97.
19. Toth PP, Potter D, Ming EE. Prevalence of lipid abnormalities in the United States: The National Health and Nutrition Examination Survey 2003-2006. J Clin Lipidol, 2012; 6: 325-330. doi: 10. 1016/j. jacl. 2012. 05. 002.
20. Bandosz P, O'Flaherty M, Drygas W et al. Decline in mortality from coronary heart disease in Poland after socioeconomic transformation: modeling study. Br Med J, 2012; 344: d8136. doi: 10. 1136/6mj. d8136.